Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In a 26-week rat oral toxicity study, AOD-9604 produced dose-dependent changes in serum osteocalcin (a bone-turnover marker) at week 13, with the direction reversing by week 26
Research context Community subcutaneous planning Amount or duration 300500 mcg per day Evidence level Anecdotal community standard Research context Published human trials Amount or duration Route and dose varied by study Evidence level Published research Research context Approved medical dosage Amount or duration None Evidence level AOD-9604 is not FDA-approved AOD-9604 Reconstitution Guide: How to Mix a 5 mg Vial A 5 mg AOD-9604 vial can be mixed with different amounts of bacteriostatic water
Enhance your long-term energy
The Bigger Concern: Leaving a Deficiency Untreated When weighing the minimal risks of B12 injections, it helps to consider the well-documented risks of an untreated B12 deficiency
&srotate=0)
